Hap Trading, LLC Graybug Vision, Inc. Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.76 - $1.25 $7,600 - $12,500	-10,000 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.13 - $1.93 $17,176 - $29,336	-15,200 Reduced 60.32%	10,000 $0
Q4 2021 Feb 14, 2022	BUY	$1.74 - $3.6 $18,270 - $37,800	10,500 Added 71.43%	25,200 $1,000
Q3 2021 Nov 10, 2021	BUY	$3.18 - $5.17 $46,746 - $75,999	14,700 New	14,700 $3,000

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.